GlaxoSmithKline Pharmaceuticals Ltd Posts Strong Q4 Profits

GlaxoSmithKline Pharmaceuticals Ltd showcased its financial resilience with a 5.7% rise in consolidated net profit for the fourth quarter, ending at Rs 277.86 crore, compared to the previous year's Rs 262.87 crore.

The company's consolidated revenue from operations for the quarter also saw an uptick, rising to Rs 995.3 crore from the last year's Rs 974.37 crore, as the company reported in a regulatory filing.

For the full fiscal year 2026, GlaxoSmithKline recorded a consolidated net profit of Rs 1,035.98 crore, marking growth over FY25's Rs 927.58 crore, while annual revenue increased to Rs 3,821.67 crore. A dividend proposal of Rs 57 per equity share awaits shareholder approval.

(With inputs from agencies.)